Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Perico
G Remuzzi

Showing results (231-240 of 551) with videos related to

Pageof 56
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 1998
Endothelin receptor antagonists: which are the therapeutic perspectives in renal diseases?A Benigni, G Remuzzi
American Journal of Hematology|February 1, 1993
Low-dose aspirin and bleeding in uremiaG Viganò, G Remuzzi
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1996
Malignant vascular disease of the kidney: nature of the lesions, mediators of disease progression, and the case for bilateral nephrectomyP Ruggenenti, G Remuzzi
Clinical and Experimental Immunology|December 12, 2007
Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritisM Noris, G Remuzzi
Kidney International|July 28, 2006
Time to abandon microalbuminuria?P Ruggenenti, G Remuzzi
Contributions to Nephrology|January 1, 1987
Proteinuria and glomerulosclerosis. New clues from experimental modelsA Remuzzi, G Remuzzi
Diabetes Research and Clinical Practice|July 3, 1998
Prognosis of diabetic nephropathy: how to improve the outcomeG Remuzzi, P Ruggenenti
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|October 9, 2002
Halting the progression of renal disease: where we stand?R C Campbell, G Remuzzi
The International Journal of Artificial Organs|July 1, 1985
The hemolytic uremic syndromeG Remuzzi, E C Rossi
Journal of Nephrology|July 1, 1997
Endothelin: a mediator of renal disease progressionI Bruzzi, G Remuzzi, A Benigni
Pageof 56

Showing results (231-240 of 551) with videos related to

Sort By:
Pageof 56
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 1998
Endothelin receptor antagonists: which are the therapeutic perspectives in renal diseases?A Benigni, G Remuzzi
American Journal of Hematology|February 1, 1993
Low-dose aspirin and bleeding in uremiaG Viganò, G Remuzzi
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1996
Malignant vascular disease of the kidney: nature of the lesions, mediators of disease progression, and the case for bilateral nephrectomyP Ruggenenti, G Remuzzi
Clinical and Experimental Immunology|December 12, 2007
Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritisM Noris, G Remuzzi
Kidney International|July 28, 2006
Time to abandon microalbuminuria?P Ruggenenti, G Remuzzi
Contributions to Nephrology|January 1, 1987
Proteinuria and glomerulosclerosis. New clues from experimental modelsA Remuzzi, G Remuzzi
Diabetes Research and Clinical Practice|July 3, 1998
Prognosis of diabetic nephropathy: how to improve the outcomeG Remuzzi, P Ruggenenti
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|October 9, 2002
Halting the progression of renal disease: where we stand?R C Campbell, G Remuzzi
The International Journal of Artificial Organs|July 1, 1985
The hemolytic uremic syndromeG Remuzzi, E C Rossi
Journal of Nephrology|July 1, 1997
Endothelin: a mediator of renal disease progressionI Bruzzi, G Remuzzi, A Benigni
Pageof 56